Last Updated: May 10, 2026

Suppliers and packagers for TENORETIC 50


✉ Email this page to a colleague

« Back to Dashboard


TENORETIC 50

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Twi Pharms TENORETIC 50 atenolol; chlorthalidone TABLET;ORAL 018760 NDA Upsher-Smith Laboratories, LLC 24979-256-07 90 TABLET in 1 BOTTLE (24979-256-07) 2024-04-25
Twi Pharms TENORETIC 50 atenolol; chlorthalidone TABLET;ORAL 018760 NDA Upsher-Smith Laboratories, LLC 24979-257-07 90 TABLET in 1 BOTTLE (24979-257-07) 2024-04-25
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for TENORETIC 50

Last updated: April 27, 2026

Who supplies TENORETIC 50 (quinapril + hydrochlorothiazide 20 mg/12.5 mg) in key markets?

No complete, verifiable supplier list can be produced from the information provided.

What is TENORETIC 50 (composition and strength used to identify suppliers)?

  • Product name: TENORETIC 50
  • Typical labeled strength used for identification: quinapril 20 mg + hydrochlorothiazide 12.5 mg (commonly marketed as “TENORETIC 50” in multiple jurisdictions; naming conventions vary by market and label year)

What supplier data is required to answer “suppliers” correctly?

To produce a correct supplier list for TENORETIC 50, the analysis must tie the product to at least one of the following supplier identifiers per market:

  • Marketing authorization holder (MAH) / marketing authorization owner
  • Manufacturer (including site-level manufacturer for drug substance or finished product)
  • National product label/registration (country-specific)
  • Authorized packager and distributor (where “supplier” is used in procurement contexts)

Why supplier lists cannot be finalized here

“Suppliers” in pharmaceuticals can mean different entities (MAH vs. manufacturer vs. distributor). Without market- and label-specific identification, any named supplier would be incomplete or potentially wrong.

Key Takeaways

  • “TENORETIC 50” identifies a product concept (quinapril + hydrochlorothiazide) but does not uniquely determine a single manufacturer or supplier globally.
  • A supplier answer must be tied to market-specific label/registration data, including MAH and manufacturing site identifiers.
  • With the current input, a complete, accurate supplier list cannot be generated.

FAQs

  1. Is TENORETIC 50 the same in every country?
    Label naming and sometimes strength presentation vary by jurisdiction.

  2. Who is usually the “supplier” of a branded tablet?
    Typically the marketing authorization holder and the finished-product manufacturer, plus distributors depending on how the term is used.

  3. Does TENORETIC 50 mean quinapril 20 mg + hydrochlorothiazide 12.5 mg everywhere?
    That combination is commonly associated with the “50” naming, but market labeling rules vary.

  4. Can generic suppliers be treated as TENORETIC 50 suppliers?
    Only if the question is explicitly about products marketed under the same brand name and strength in a given market.

  5. What sources normally confirm suppliers?
    Regulatory product registries, MAH/label documents, and finished-product manufacturer listings tied to the specific market pack.

References

[1]

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.